RedHill Biopharma Ltd. (RDHL) To Host First Quarter 2014 Financial Results Conference Call On May 1, 2014
4/29/2014 9:41:01 AM
TEL-AVIV, Israel, April 29, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the "Company" or "RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary drugs for the treatment of inflammatory and gastrointestinal diseases including cancer and related conditions, today announced that it will host a conference call on Thursday, May 1, 2014, at 9:00 a.m. ET to review the Company's first quarter 2014 financial results and business highlights.
Help employers find you! Check out all the jobs and post your resume.
comments powered by